Real case · VASER 360° liposculpture
VASER 360° liposculpture with fat transfer to the hips and buttocks
A slim patient who was not happy with her figure: fat accumulated around the waist, with a more masculine distribution, and she had very marked hip dips. Dr. Mecott removed fat from the abdomen, waist and lower back and placed it in the hips and buttocks to build a feminine silhouette.
- Procedure
- VASER 360° liposculpture
- Fat transfer
- Hips and buttocks (known as BBL)
- Liposuction areas
- Abdomen, waist and lower back
- Approximate duration
- 3 to 4 hours
- Hospital stay
- Outpatient
- Back to work
- 10 to 14 days
- Compression garment
- 24/7 for 4 weeks and 2 more weeks of intermittent use
What she was looking for
Although she was slim, the fat she had accumulated in areas that gave her body a shape different from the one she wanted. She had also always wanted a better buttock shape.
What the doctorobserved
Firm skin and relatively little fat, accumulated mostly around the waist. Very marked hip dips and little waist definition, which gave her figure a not very feminine appearance.
The strategy
Removing the fat from the abdomen, waist and lower back with VASER and placing it in the hips and buttocks, in the proportion needed to enhance her feminine features. Since her skin was firm, no skin needed to be removed.
The result andwhat was preserved
A light marking of the abdomen was done (soft definition), the hip dips were filled, and as much fat as possible was removed from the waist and lower back. The change is in the proportions: a more defined waist in relation to the hips and buttocks, and a feminine silhouette overall.
Before and after
This section contains medical photographs.

Before

After

Before

After

Before

After
Before
After
Before and [X months] after surgery. Results vary from patient to patient.
The doctor explainsthe case
Transcript
Case documented by Dr. Gabriel Ángel Mecott Rivera, board-certified plastic surgeon (certification No. 1379, specialty license 5225369). Published with the patient's written consent. Cofepris advertising notice 2619032002A00352.
